Observational studies and smaller clinical trials have examined men with obesity and type 2 diabetes treated with GLP-1 receptor agonists, including semaglutide
As may be expected, mean diabetes duration tended to be longer in patients receiving a greater number of background medications, ranging from 7.2 to 10.6 years in patients on metformin monotherapy to 8.4 to 17.3 years in patients receiving more than one background medication
Without insurance, a months supply of semaglutide is typically under $1,870
No, patients should continue prescribed arthritis medications and maintain comprehensive joint care as directed by their healthcare providers
For laboratory and research use only
To do the math for you, thats about a fifth of their body weight = ~ 22 kg = almost 49 lbs